Skip to main content
Oncotarget logoLink to Oncotarget
. 2018 Jul 20;9(56):30936. doi: 10.18632/oncotarget.25856

Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes

M Teresa Cedena 1,2,#, Inmaculada Rapado 1,2,#, Alejandro Santos-Lozano 2,3, Rosa Ayala 1,2, Esther Onecha 1,2, María Abaigar 4, Esperanza Such 5, Fernando Ramos 6, José Cervera 5,7, María Díez-Campelo 4,8, Guillermo Sanz 5, Jesús Hernández Rivas 4,8, Alejandro Lucía 2,9, Joaquin Martínez-López 1,2
PMCID: PMC6089387  PMID: 30112119

This article has been corrected: In the Materials and Methods section, the data access link is incorrect. In addition, reference 37 was also listed incorrectly. The proper information is given below:

Materials and Methods: The data discussed in this publication have been deposited in the NCBI Sequence Read Archive (SRA) [37] and are accessible through (http://www.ncbi.nlm.nih.gov/sra/SRP102906).

References: 37. Leinonen R, Sugawara H, Shumway M. The sequence read archive. Nucleic Acids Res. 2011; 39 (Database issue): D19-D21.

Original article: Oncotarget. 2017; 8:106948-106961. https://doi.org/10.18632/oncotarget.22157


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES